Perrigo (PRGO) Cash from Restructuring (2023 - 2026)
Perrigo's (PRGO) quarterly Cash from Restructuring came in at $71.4 million in Q1 2026, up 142.86% year-on-year from $29.4 million in Q1 2025, and up 142.86% on a QoQ basis from $29.4 million in Q1 2025.
Perrigo (PRGO) Cash from Restructuring (2023 - 2026) Analysis & Trends
Perrigo (PRGO) has 4 years of Cash from Restructuring data on file, last reported at $71.4 million in Q1 2026.
- On a quarterly basis, Cash from Restructuring rose 142.86% year-over-year to $71.4 million in Q1 2026; TTM through Mar 2026 was $162.4 million, a 52.63% increase from a year earlier, with the FY2025 full-year figure at $67.0 million, down 32.93% from the prior year.
- Cash from Restructuring for Q1 2026 stood at $71.4 million, up from $29.4 million in the prior quarter.
- Over the last five years, Cash from Restructuring for PRGO reached as high as $71.4 million in Q1 2026 and fell as low as $4.8 million in Q3 2024.
- Historically, Cash from Restructuring has averaged $32.2 million across 4 years, with a median of $22.4 million in 2023.
- On a YoY basis, Cash from Restructuring climbed as much as 268.83% in 2024 and fell as far as 69.03% in 2024.
- Year by year, Cash from Restructuring stood at $15.4 million in 2023, then surged by 268.83% to $56.8 million in 2024, then plunged by 48.24% to $29.4 million in 2025, then jumped by 142.86% to $71.4 million in 2026.
- Per Business Quant data, the three most recent Cash from Restructuring figures were $71.4 million in Q1 2026, $29.4 million in Q1 2025, and $56.8 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Perrigo | 1.40 Bn | 1.05 Bn | 325.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 71.40 Mn |
| Mar 29, 2025 | 29.40 Mn |
| Dec 31, 2024 | 56.80 Mn |
| Sep 28, 2024 | 4.80 Mn |
| Dec 31, 2023 | 15.40 Mn |
| Sep 30, 2023 | 15.50 Mn |